Nearly three years after…
Nearly three years after originating the role, Erica Taylor, Ph.D., [...]
Nearly three years after originating the role, Erica Taylor, Ph.D., [...]
After Carisma Therapeutics laid off 95% of its team earlier [...]
Biogen has given Alcyone Therapeutics a starring role in its [...]
VectorY Therapeutics has seen the shape of things to come—and [...]
Having already stripped back their development plans for the estrogen [...]
Roche dived into the metabolic dysfunction-associated steatohepatitis space by agreeing [...]
Beijing QL Biopharmaceutical has shared phase 2 data on its [...]
Merck is stepping up to the plate to raise awareness [...]
One of the top fundraisers of 2024 is halving its [...]
Former CDC Director Susan Monarez, Ph.D., told senators the health [...]